PRELUDE CAPITAL MANAGEMENT, LLC - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2022$362,0000.0%21,704
+92.1%
0.01%
+44.4%
Q4 2021$362,000
+24.4%
11,300
+39.6%
0.01%
+28.6%
Q3 2021$291,000
-17.6%
8,095
+1.3%
0.01%
-30.0%
Q2 2021$353,0007,9910.01%
Other shareholders
PULMONX CORP shareholders Q2 2021
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 994,971$43,898,0008.08%
ABG-WTT Global Life Science Capital Partners GP Ltd 93,831$4,140,0008.00%
Miura Global Management 570,000$25,148,0004.59%
Iron Triangle Partners LP 550,000$24,266,0002.50%
Beck Bode, LLC 116,442$5,137,0001.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,800,887$79,455,0001.41%
Affinity Asset Advisors, LLC 60,000$2,647,0000.95%
PURA VIDA INVESTMENTS, LLC 595,231$26,262,0000.82%
RTW INVESTMENTS, LP 1,129,600$49,838,0000.75%
ABG Innovation Capital Partners III GP Ltd 4,521$199,0000.67%
View complete list of PULMONX CORP shareholders